Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

The rapid advancement of Artificial Intelligence has moved us from simple chatbots to autonomous agents. These agents do not just answer questions; they plan, use tools, and execute tasks with minimal ...

Apple’s popular news app has been aggressively promoting articles from left-leaning news outlets – even as it has all but shut down posts from more conservative publications, according to an explosive ...

This language could very well describe de La Tour du Pin’s assemblages. Ultimately, her atmospheric meditation on material transformations appears to rely more on elegant ambiguity than on conceptual ...

What we are facing with AI is a world in which the systems we depend on are too complex to fully understand, too embedded to ...

AI startup Anthropic's claim of automating COBOL modernization sent IBM's stock plummeting, wiping billions off its market value. The decades-old language, still powering critical systems, faces a ...

There’s a snapshot in time that will forever live in the mind of Afton native Jessie Diggins, and it’s not the epic finishing kick at the 2018 Winter Olympics in Pyeongchang, South Korea, that ...

My academic funding was running out and my patience with the delirious pace of start-up culture had run thin. You might say I ...

T-accounts are one of accounting’s most useful visual tools, and they’ve stuck around for good reason. Named for their simple T shape, these diagrams split a ledger account into two sides. Debits go ...